HC Wainwright Cuts Tempus AI (NASDAQ:TEM) Price Target to $56.00

Tempus AI (NASDAQ:TEM) had its target price decreased by HC Wainwright from $64.00 to $56.00 in a research report report published on Monday morning, Marketbeat Ratings reports. HC Wainwright currently has a buy rating on the stock.

TEM has been the topic of a number of other research reports. Jefferies Financial Group initiated coverage on Tempus AI in a research report on Monday, April 13th. They issued an “underperform” rating and a $35.00 target price on the stock. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Tuesday, June 2nd. They set a “peer perform” rating for the company. Stifel Nicolaus lowered their price objective on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a report on Monday. Weiss Ratings restated a “sell (e+)” rating on shares of Tempus AI in a report on Wednesday, June 17th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 target price on shares of Tempus AI in a research report on Friday, July 31st. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Tempus AI has a consensus rating of “Hold” and a consensus target price of $64.92.

Tempus AI Stock Down 0.7%

Shares of TEM stock opened at $46.70 on Monday. Tempus AI has a 12-month low of $40.77 and a 12-month high of $104.32. The company has a quick ratio of 3.16, a current ratio of 3.30 and a debt-to-equity ratio of 3.06. The firm has a fifty day moving average of $51.40 and a 200-day moving average of $52.12. The company has a market capitalization of $8.39 billion, a price-to-earnings ratio of -32.43 and a beta of 3.58.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.10. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The firm had revenue of $382.49 million during the quarter, compared to analyst estimates of $379.69 million. During the same period in the prior year, the business earned ($0.22) EPS. The company’s revenue for the quarter was up 21.6% compared to the same quarter last year. As a group, equities research analysts predict that Tempus AI will post -1.35 earnings per share for the current fiscal year.

Insider Transactions at Tempus AI

In related news, CAO Ryan M. Bartolucci sold 4,116 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total value of $181,392.12. Following the completion of the sale, the chief accounting officer directly owned 74,041 shares in the company, valued at approximately $3,262,986.87. This trade represents a 5.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Eric P. Lefkofsky sold 250,000 shares of Tempus AI stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $42.06, for a total value of $10,515,000.00. Following the transaction, the chief executive officer owned 200,000 shares of the company’s stock, valued at $8,412,000. The trade was a 55.56% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 723,981 shares of company stock valued at $34,879,442. 24.26% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Handelsbanken Fonder AB raised its stake in Tempus AI by 4.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 32,900 shares of the company’s stock valued at $1,906,000 after acquiring an additional 1,300 shares during the period. CoreCap Advisors LLC boosted its position in Tempus AI by 293.4% during the second quarter. CoreCap Advisors LLC now owns 1,019 shares of the company’s stock worth $59,000 after purchasing an additional 760 shares during the period. NewEdge Advisors LLC boosted its position in Tempus AI by 1.3% during the first quarter. NewEdge Advisors LLC now owns 42,996 shares of the company’s stock worth $1,944,000 after purchasing an additional 536 shares during the period. Avidity Partners Management LP bought a new position in Tempus AI during the first quarter worth $1,130,000. Finally, Silverback Asset Management LLC increased its holdings in shares of Tempus AI by 44.5% in the first quarter. Silverback Asset Management LLC now owns 35,700 shares of the company’s stock valued at $1,614,000 after purchasing an additional 11,000 shares during the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.